1. Home
  2. VPG vs SPTX Comparison

VPG vs SPTX Comparison

Compare VPG & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vishay Precision Group Inc.

VPG

Vishay Precision Group Inc.

HOLD

Current Price

$103.75

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$21.27

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VPG
SPTX
Founded
2009
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
2010
2026

Fundamental Metrics

Financial Performance
Metric
VPG
SPTX
Price
$103.75
$21.27
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$53.50
N/A
AVG Volume (30 Days)
464.2K
124.7K
Earning Date
05-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$307,202,000.00
N/A
Revenue This Year
$7.21
N/A
Revenue Next Year
$6.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.22
N/A
52 Week Low
$25.58
$17.59
52 Week High
$151.78
$22.98

Technical Indicators

Market Signals
Indicator
VPG
SPTX
Relative Strength Index (RSI) 41.93 58.35
Support Level $93.34 $18.47
Resistance Level $150.08 $22.12
Average True Range (ATR) 7.38 1.76
MACD -1.16 0.04
Stochastic Oscillator 38.92 74.03

Price Performance

Historical Comparison
VPG
SPTX

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: